Search

Your search keyword '"Stolk, Wilma A"' showing total 439 results

Search Constraints

Start Over You searched for: Author "Stolk, Wilma A" Remove constraint Author: "Stolk, Wilma A"
439 results on '"Stolk, Wilma A"'

Search Results

1. Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?

5. Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

6. Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium.

7. Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study

8. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis

9. An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale

10. Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?

11. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?

13. Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy

15. Impact of ivermectin and vector control on onchocerciasis transmission in Togo:Assessing the empirical evidence on trends in infection and entomological indicators

16. Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy

17. Predictive Value of Microfilariae-Based Stop-MDA Thresholds after Triple Drug Therapy with IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings

18. Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets:How Can Quantitative Modeling Support Programmatic Decisions?

19. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?

20. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa:a systematic review and meta-analysis

21. An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale

22. Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators.

26. Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone

32. Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions

35. Onchocerciasis-associated epilepsy in Maridi, South Sudan:Modelling and exploring the impact of control measures against river blindness

37. Elimination of Transmission of Onchocerciasis with Long-Term Ivermectin Mass Drug Administration with or Without Vector Control in Sub-Saharan Africa: A Systematic Review and Meta-Analysis

38. Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa

39. Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study

42. Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions

43. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa–Endemic Areas

44. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

45. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

46. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

47. Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa

48. Onchocerciasis:Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions

49. How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases

50. How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases

Catalog

Books, media, physical & digital resources